Showing 2001-2010 of 4274 results for "".
- Study Shows Preventive Effects and Protective Potential of Astaxanthin on Collagen Damagehttps://modernaesthetics.com/news/study-shows-preventive-effects-and-protective-potential-of-astaxanthin-on-collagen-damage/2473411/A study recently found that Lycored's astaxanthin prevented against collagen damage from neutrophils, discovering its potential to protect collagen and enhance skin health. The study,
- Merz Aesthetics Adds SaltFacial to Portfolio of Productshttps://modernaesthetics.com/news/merz-aesthetics-adds-saltfacial-to-portfolio-of-products/2473332/Merz Aesthetics and SaltMED are extending their commercial agreement adding The SaltFacial by SaltMED to the portfolio of products offered by Merz Aesthetics. The SaltFacial is a skin rejuvenation system that targets the texture, tone ,and color of skin. The S
- Colorescience Finishing Touch Protocol Boosts Patient Satisfaction after Microneedling RFhttps://modernaesthetics.com/news/colorescience-finishing-touch-protocol-boosts-patient-satisfaction-after-microneedling-rf/2473243/Colorescience’s Finishing Touch post-treatment skincare protocol improves patient confidence, comfort, satisfaction, and increases the likelihood of a repeat radiofrequency microneedling procedure, according to research in The Journal of Clinical and Aesthetic Dermatology
- Hallura’s New BiOLinkMatrix HA Aesthetic Dermal Fillers Perform Well in Lips, Cheeks, and Smile Lineshttps://modernaesthetics.com/news/halluras-new-biolinkmatrix-ha-aesthetic-dermal-fillers-performs-well-in-lips-cheeks-and-smile-lines/2473203/Hallura Ltd’s hyaluronic acid (HA) dermal fillers with its proprietary BiOLinkMatrix platform performed well for lip enhancement, nasolabial folds correction. and cheek enhancement, according to topline results. The pro
- Retinol Plus CBD Maintains Anti-Aging Properties without Harsh Side Effectshttps://modernaesthetics.com/news/retinol-plus-cbd-maintains-anti-aging-properties-without-harsh-side-effects/2473189/Combining a retinol and cannabidiol (CBD) in topical skincare maintains retinol’s anti-aging properties with reduced side effects, a new study in A
- CollPlant’s rhCollagen-based Photocurable Dermal Filler Shows Promise for Facial Lifting and Sculpting and Breast Augmentation/Reconstructionhttps://modernaesthetics.com/news/collplants-rhcollagen-based-photocurable-dermal-filler-shows-promise-for-facial-lifting-and-sculpting-and-breast-augmentationreconstruction/2473173/CollPlant's photocurable dermal filler may enhance cell proliferation and new tissue regeneration for facial lifting and sculpting plus breast augmentation and reconstruction , according to
- SkinSAFE Names Top 25 2021 Sunscreen Award Winners for Sensitive Skinhttps://modernaesthetics.com/news/skinsafe-names-top-25-2021-sunscreen-award-winners-for-sensitive-skin/2473111/SkinSAFE partnered with CVS Pharmacy, through the retailer's "Sensitive-Friendly" program, for the first-ever awards that recognize popular products that are safe for sensitive skin types. The experts at
- Nutrafol Launches Pro-Strength Boostershttps://modernaesthetics.com/news/nutrafol-launches-pro-strength-boosters/2473071/New professional-strength boosters from Nutrafol extend the popular nutraceutical line, providing physicians the opportunity to individualize recommendations for each patient’s specific hair health needs. Hairbiotic MD is a professional-strength
- Evolus’ Jeuveau Can Stay on U.S. Market For Nowhttps://modernaesthetics.com/news/evolus-jeuveau-gets-stay-of-execution/2473061/Evolus Inc. can remain for sale in the U.S. temporarily while an appeals court re-considers an import ban won by AbbVie Inc.’s Allergan that was slated to go into effect on Feb. 16, 2021, according to
- Revance Update: FDA Defers Approval of DaxibotulinumtoxinA Due to COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspectionhttps://modernaesthetics.com/news/revance-update-fda-defers-approval-of-daxibotulinumtoxina-due-to-covid-19-related-travel-restrictions-impacting-manufacturing-site-inspection/2473027/The U.S. Food and Drug Administration (FDA) deferred a decision on the Biologics License Application (BLA) for Revance’s DaxibotulinumtoxinA for Injection, an investigational neuromodulator product for the treatment of moderate to severe glabellar lines. In a communication r